Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORSAR trial of prednisone in adult septic arthritis
2025-522193-37-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in infectious arthritis (SA) comparing Prednisone plus antibiotics with Placebo plus antibiotics (2 arms). Primary endpoint: Functional assessment score at week 24. Planned start Jun 2026; status: authorised.
02
Drugs
prednisone
03
Conditions
infectious arthritis (SA)
Beyond the preview
Go deeper on 2025-522193-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522193-37-00.